Robert Williamson 讣告:定位囊性纤维化与杜氏肌营养不良症相关基因的遗传学家
Robert Williamson obituary: geneticist who mapped genes for muscular dystrophy and cystic fibrosis
遗传学家 Robert Williamson 的讣告指出,他利用 DNA 标记定位了囊性纤维化和杜氏肌营养不良症相关基因在染色体上的位置。这推动了 DMD 相关基因变异携带者的基因检测,并扩展了对受累家庭的遗传咨询。他还关注群体遗传筛查和干细胞研究的伦理问题,移居澳大利亚后为
- OBITUARY
- 21 October 2026
Researcher and policy adviser who championed tests and treatments for genetic diseases.
By
-
Kay E. Davies
-
Kay E. Davies is Dr Lee’s Professor of Anatomy emeritus at the University of Oxford, Oxford, UK. She was a research fellow with Williamson at St Mary’s Hospital.
-

Credit: Prudence Cuming Associates/The Royal Society
Robert (Bob) Williamson was a geneticist who dedicated his career to the identification of disease-linked genes and the diagnosis and treatment of single-gene disorders. He was concerned about the ethical implications of population-wide genetic screening and using stem cells in research. Williamson was one of the first to use DNA markers to locate the position of important human disease-associated genes on chromosomes. He mapped the location of genes linked to cystic fibrosis (CF) and Duchenne muscular dystrophy (DMD). This led to the development of genetic tests to identify people who carried DMD-related gene alterations, extending the range of counselling provided to affected families.
He was an astute politician, bringing together people from across the field of health care — from genetic research to the bedside — and working closely with patient advocacy groups and the UK government. After moving from the United Kingdom to Australia, he became interested in national science policy and medical and scientific ethics. There, he advised several premiers and ministers.
All the ways a cell can die — and why the variety matters
Williamson was born in Cleveland, Ohio, and spent his childhood in New York City. When he was 16 years old, his family moved to London. After doing undergraduate and graduate degrees in chemistry at University College London, Williamson moved to the University of Glasgow, UK, in 1963 to become a lecturer in developmental biology. There, his research focused on globin genes, which encode the protein components of the oxygen-carrying haemoglobin molecule. His group showed that blood disorders known as thalassaemias were often caused by deletions in the genes encoding α-globin and fetal haemoglobin. He later collaborated with others to develop prenatal diagnosis and testing methods for carriers of these disorders.
His work on haemoglobin synthesis in immature red blood cells led him to study the control of gene expression. Puzzled about unexpected free-floating DNA fragments that hindered his work, he reported in 1970 that this cell-free DNA was released by the nuclei of cells that had died during development (R. Williamson J. Mol. Biol. 51, 157–160; 1970). In the same paper, he described the ‘nucleosome ladder’, a gel-electrophoresis pattern that reflected how DNA was organized in chromosomes. Williamson was particularly proud that these observations were recognized; his paper was published three years before the biological importance of nucleosomes was realized and several decades before cell-free DNA became a valuable diagnostic tool for cancer and other conditions.
CRISPR’s next act: the companies editing the epigenome to treat disease
Nature 658, 1127 (2026)
doi: https://doi.org/10.1038/d41586-026-03375-7
Competing Interests
The author declares no competing interests.
Related Articles
-
CRISPR’s next act: the companies editing the epigenome to treat disease
-
‘It’s a vote for hope’: first gene therapy for muscular dystrophy nears approval, but will it work?
-
DeepMind’s new genome ‘atlas’ charts effects of all 9 billion human gene mutations
Subjects
Latest on:
-
Is it ‘moon-stroke’, or a chill?
News & Views 20 OCT 26
-
History’s long-secret codes are being cracked by amateurs using AI
News 16 OCT 26
-
Margaret Hamilton obituary: computer scientist who pioneered software engineering and helped us get to the Moon
Obituary 15 OCT 26
来源:Nature 健康护理主题 · nature.com


All the ways a cell can die — and why the variety matters